Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Merker

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|February 18, 2015
Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous systemAnna R Terry, Vanessa L Merker, Fred G Barker, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2012
Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patientsScott R Plotkin, Vanessa L Merker, Chris Halpin, et al.
Journal of Neuro-Oncology|January 7, 2015
Examining perceived cancer risk among patients with neurofibromatosis type 1Elyse R Park, Kelly B Smith, Vanessa L Merker, et al.
American Journal of Medical Genetics. Part A|February 18, 2017
First report of factors associated with satisfaction in patients with neurofibromatosisEric Riklin, Mojtaba Talaei-Khoei, Vanessa L Merker, et al.
Skeletal Radiology|December 8, 2011
Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosisJacob L Jaremko, Peter J MacMahon, Martin Torriani, et al.
Journal of Neuro-Oncology|December 1, 2016
First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosisMojtaba Talaei-Khoei, Eric Riklin, Vanessa L Merker, et al.
Clinical Nuclear Medicine|October 25, 2013
Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusionTrinity Urban, Ruth Lim, Vanessa L Merker, et al.
Journal of General Internal Medicine|March 29, 2022
Evaluating the Impacts of Patient Engagement on Health Services Research Teams: Lessons from the Veteran Consulting NetworkVanessa L Merker, Justeen K Hyde, Abigail Herbst, et al.
Neurology|November 20, 2013
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.
Journal of Neuro-Oncology|November 10, 2017
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTTVanessa L Merker, Sarah McDannold, Eric Riklin, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|February 18, 2015
Pregnancy complications in women with rare tumor suppressor syndromes affecting central and peripheral nervous systemAnna R Terry, Vanessa L Merker, Fred G Barker, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 19, 2012
Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patientsScott R Plotkin, Vanessa L Merker, Chris Halpin, et al.
Journal of Neuro-Oncology|January 7, 2015
Examining perceived cancer risk among patients with neurofibromatosis type 1Elyse R Park, Kelly B Smith, Vanessa L Merker, et al.
American Journal of Medical Genetics. Part A|February 18, 2017
First report of factors associated with satisfaction in patients with neurofibromatosisEric Riklin, Mojtaba Talaei-Khoei, Vanessa L Merker, et al.
Skeletal Radiology|December 8, 2011
Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosisJacob L Jaremko, Peter J MacMahon, Martin Torriani, et al.
Journal of Neuro-Oncology|December 1, 2016
First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosisMojtaba Talaei-Khoei, Eric Riklin, Vanessa L Merker, et al.
Clinical Nuclear Medicine|October 25, 2013
Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusionTrinity Urban, Ruth Lim, Vanessa L Merker, et al.
Journal of General Internal Medicine|March 29, 2022
Evaluating the Impacts of Patient Engagement on Health Services Research Teams: Lessons from the Veteran Consulting NetworkVanessa L Merker, Justeen K Hyde, Abigail Herbst, et al.
Neurology|November 20, 2013
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.
Journal of Neuro-Oncology|November 10, 2017
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTTVanessa L Merker, Sarah McDannold, Eric Riklin, et al.
Pageof 8